 bronchial challeng adenosin releas serum neutrophil chemotact factor asthma order mechan adenosine-induc bronchoconstrict asthma serum neutrophil chemotact activ nca normal individu patient asthma min bronchoprovoc adenosin challeng test concentr mg/ml particip group asthmat hyperrespons group asthmat hyperrespons adenosin group normal subject group mean percentag increas nca group group group signific increas nca histamin challeng individu asthma group patient group treatment therapeut dose oral theophyllin theophyllin therapi signific attenu increas nca concentr adenosin decreas treatment concentr adenosin drop twofold patient analysi nca gel filtrat chromatographi increas high molecular weight chemotact factor serum group patient adenosin challeng releas high molecular weight chemotact factor consist mast cell sourc inflammatori mediat adenosine-induc bronchoconstrict therapeut effect theophyllin potent adenosin antagonist asthma occur part inhibit process